daunorubicin has been researched along with Autoimmune Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Llorente, L; López-Karpovitch, X; Richaud-Patin, Y; Ruiz-Soto, R | 1 |
Cobos, E; Keung, YK; Morgan, D | 1 |
Christadoss, P; Henderson, R; Keve, S | 1 |
Diener, E; Diner, UE; Sinha, A; Vergidis, R; Xie, S | 1 |
4 other study(ies) available for daunorubicin and Autoimmune Disease
Article | Year |
---|---|
Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoimmune Diseases; Biomarkers; Case-Control Studies; Daunorubicin; Female; Flow Cytometry; Humans; Lymphocytes; Male; Middle Aged; Prognosis; Purpura, Thrombocytopenic, Idiopathic | 2003 |
Cocaine-contaminated allogeneic bone marrow transplantation.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bone Marrow Transplantation; Cocaine-Related Disorders; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Graft Survival; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Marijuana Abuse; Middle Aged; Recurrence; Salvage Therapy; Thrombocythemia, Essential; Tissue and Organ Procurement; Tissue Donors; Transplantation, Homologous | 2001 |
Daunomycin treatment prevents clinical expression of experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Body Weight; Daunorubicin; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Myasthenia Gravis; Organ Size; Receptors, Cholinergic | 1991 |
Specific immunosuppression by immunotoxins containing daunomycin.
Topics: Animals; Autoimmune Diseases; Concanavalin A; Daunorubicin; Fluorescein; Fluoresceins; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred CBA; Nitrohydroxyiodophenylacetate; Ovalbumin; Picrates; Spleen; T-Lymphocytes | 1986 |